SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Caplin Point selected under Forbes Asia’s ‘200 best under billion list’

22 Aug 2022 Evaluate

Caplin Point Laboratories has been selected under Forbes Asia’s 200 Best Under a Billion list for 2022. Forbes Asia has selected 200 best performing companies, with revenues of less than a billion, from a list of over 17,000 public listed companies across the Asia-Pacific.

Caplin Point has also been ranked 1 in India for “Most Consistent Profitable Growth across last 10 years” by Value Research magazine in the Wealth Insight June 2022 issue.

Caplin Point Laboratories is engaged mainly in manufacturing a wide range of Ointments, Creams and other External application preparations in addition to the regular segments of pharmaceutical formulations.

Caplin Point Lab Share Price

1772.50 6.05 (0.34%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×